IQVIA HOLDINGS INC.
For the period ended Apr 23, 2026. Filed Feb 27, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 23, 2026 · Filed Feb 27, 2026
Contents
Benchmarking
The LDC Committee works with our external compensation consultant to better understand and continually monitor market-competitive pay practices, which it then considers when determining compensation adjustments and changes for the coming year. This annual process includes reviewing our identified peer group and conducting a competitive market benchmark analysis of senior officer roles. The LDC Committee also considers, on a supplemental basis, market survey data from the Aon Radford Survey when determining the elements and amount of total direct compensation for our named executive officers.
2025 Compensation Peer Group
The LDC Committee generally targets total target compensation opportunities for our named executive officers, other than our Chief Executive Officer, at or near the median of our peer group but retains flexibility to position named executive officers above or below median based on experience, scope of responsibility, critical skill set, expertise and performance. The LDC Committee considers comparisons to compensation levels at other companies to be helpful in
| 52 | IQVIA HOLDINGS INC. | 2026 Proxy Statement |
assessing the overall competitiveness of our compensation practices, but places a greater emphasis on aligning overall compensation opportunities rather than individual compensation elements.
The compensation peer group used by the LDC Committee to review our named executive officers’ total target compensation in July 2025 was reviewed by the LDC Committee in May 2025 with no changes to the peer group from the prior year. In 2023, to better align the peer group with the Company’s strategic objectives, the external compensation consultant recommended, and the Company implemented, significant changes to the criteria used to select the Company’s peer group. The following criteria are used as guidelines for selecting peer group companies:
| Industry Classification | U.S. publicly-traded companies in related industry segments with strategic filters for global complexity and growth orientation |
| Revenue | Revenue range of 0.25x to 4.0x IQVIA’s trailing 12-month revenue |
| Market Capitalization | 12-month average market capitalization at least 0.5 of IQVIA and 2x three-year average revenues as exemplified by high growth/ high margin strategies |
| Non-U.S. Revenue | >25% non-U.S. revenues |
The following companies constitute the Company’s peer group, which applies to all of our named executive officers, including our Chief Executive Officer. No changes were made in 2025.
| Industry | Company Name |
| Biotechnology | AbbVie Inc.Amgen Inc.Biogen Inc.Gilead Sciences, Inc.Moderna, Inc.Regeneron Pharmaceuticals, Inc. Vertex Pharmaceuticals Inc. |
| Healthcare Services | Laboratory Corp of America Holdings |
| IT Consulting and Services | Accenture plcCognizant Technology Solutions Corp. Gartner, Inc.International Business Machines Corp. |
| Life Science Tools and Services | Agilent Technologies, Inc.Avantor, Inc.Danaher CorporationICON plcThermo Fisher Scientific, Inc. |
| Pharmaceuticals | Bristol Myers Squibb Co.Eli Lilly & Co.Merck & Co., Inc.Pfizer Inc.Zoetis Inc. |
Non-binding Company grant guidelines
Long-term incentive award values are determined in part based on non-binding Company grant guidelines, which the LDC Committee develops each year. These guidelines set forth proposed long-term target award values for our named executive officers and are established to be consistent with peer group and market survey data on target equity award values for employees with similar positions.
| IQVIA HOLDINGS INC. | 2026 Proxy Statement | 53 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.